PBLA: Panbela Therapeutics, Inc. Stock

by  •  • Comments Off on PBLA: Panbela Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1.99
Enterprise Value ($M) 8.24
Book Value ($M) -18.17
Book Value / Share -3.74
Price / Book -0.11
NCAV ($M) -18.17
NCAV / Share -3.74
Price / NCAV -0.11

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -2.37
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.26
Current Ratio 0.26

Balance Sheet (mrq) ($M)
Current Assets 5.17
Assets 5.17
Liabilities 23.34
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
10-29 13D Nant Capital, LLC 33.33
2024-02-13 13G/A Lind Global Fund II LP 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-26 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)

Similar Companies
OVIT – OncoVista Innovative Therapies, Inc. OWPC – One World Products, Inc.
PBAJ – Petro USA, Inc. PCNT – Point of Care Nano-Technology, Inc.
PCYN – Procyon Corporation


Financial data and stock pages provided by
Fintel.io